The Investor’s Role in the Fight against AMR: Investing Responsibly to Maximise Impact
Note: This description is sourced from the original post. We recommend reading the full post on the event site.
Details
In partnership with the World Health Organization (WHO), the Access to Medicine Foundation is hosting a live webinar in recognition of World AMR Awareness Week (WAAW) 2025. The one-hour session will centre around the threat of AMR to the global economy, narrowing in on the role investors can play in helping to curb the impact.
In partnership with the World Health Organization (WHO), the Foundation is hosting a live webinar entitled ‘The Investor’s role in the fight against AMR: Investing responsibly to maximise impact.’ The session will cover:
- AMR’s implications for market resilience and long-term investment returns
- How pharmaceutical companies are addressing AMR, including best practices and ongoing initiatives
- Areas where more action is needed and how investors can accelerate company action within those areas
- Practical solutions and accountability mechanisms that can be used to evaluate companies’ performance on AMR and ensure commitments turn into measurable impact
Moderator:
Claudia Martínez, Director of Research, Access to Medicine Foundation
Panelists:
Valeria Gigante, Team Lead, AMR Department, WHO
Jaideep A Gogtay, Global Chief Medical Officer, Cipla
Maria Souza, Senior Impact Analyst, Baillie Gifford
Evelyn Wesangula, Senior AMR Control Specialist, East Central and Southern Africa Health Community (ECSA- HC)